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This study demonstrates that the levels of gB-specific IgG and IgA in vaginal washes of mice immunized intranasally (i.n.)
with a recombinant adenovirus vector expressing herpes simplex virus (HSV) glycoprotein B (AdgB8) vary inversely with
each other and are dependent on the stage of the estrous cycle. Anti-gB IgA titers in vaginal washes were significantly
higher during estrus than diestrus or proestrus, whereas specific IgG titers were significantly higher during diestrus than
estrus. This was further demonstrated in hormone-treated mice, where progesterone administration induced a diestrus-like
state that resulted in elevated specific IgG-to-IgA ratios. Interestingly, unimmunized mice were only susceptible to intravaginal
(ivag) infection with HSV-2 during diestrus. Mice immunized i.n. with AdgB8 and given progesterone were protected from
a lethal intravaginal HSV-2 challenge, despite the fact that virus replication was present for 4 days postchallenge. Further,
high numbers of gB-specific IgA and IgG antibody-secreting cells were present in both the genital tracts and the draining
iliac lymph nodes of i.n.-immunized, but not unimmunized, mice 6 days following ivag HSV-2 challenge. These results
demonstrate that the levels of specific antibodies in the female genital tract are dependent on the stage of the estrous
cycle. Furthermore, i.n. AdgB8 immunization provided a significant level of protection and specific IgA and IgG antibody-
secreting cells in the genital tissues during resolution of an ivag infection with HSV-2. q 1996 Academic Press, Inc.
INTRODUCTION of the murine genital tract is mainly a result of active
transport by secretory component (SC) through the uter-
Antibodies in the mucosal secretions of the genital ine epithelium, whereas IgG found in cervicovaginal se-
tract represent the first specific immune barrier against cretions is generally due to transudation through the vag-
the penetration of sexually transmitted pathogens inal epithelium (Brandtzaeg et al., 1994; Mestecky, 1987;
(Brandtzaeg et al., 1994; Mestecky, 1987; Mestecky et Mestecky et al., 1994; Parr and Parr, 1990, 1994a; Under-
al., 1994; Mogens and Russell, 1994). Antibodies of both down and Mestecky, 1994). The levels of SC and total
IgG and IgA isotypes are present in genital secretions immunoglobulins in the female genital tract have been
and both have been shown to be important in this protec- reported to change over the course of the estrous cycle
tion (Brunham et al., 1983; Eis-Hubinger et al., 1993; Mer- (Sullivan and Wira, 1983; Wira and Sandoe, 1977, 1980;
riman et al., 1984; Mogens and Russell, 1994; Whaley et Wira et al., 1994). In rodents, SC is present at its highest
al., 1994). Secretory IgA is particularly well suited for levels in uterine fluids during proestrus and estrus (Sulli-
mucosal surfaces due to its greater avidity and resis- van and Wira, 1983). Since SC is responsible for deliv-
tance to proteolytic cleavage (Magnusson and Stjern- ering IgA to the mucosal surface it is not surprising that
strom, 1982; Mogens and Russell, 1994). Although the total IgA levels in rat uterine secretions were significantly
primary function of IgA has been regarded as the ability
higher during estrus and proestrus when compared to
to neutralize pathogens at the mucosal surface (Mogens
diestrus (Wira and Sandoe, 1977, 1980; Wira et al., 1994).
and Russell, 1994), more recently, in vitro (Mazanec et
The levels of total IgG have also been shown to change
al., 1992, 1995) and in vivo (Burns et al., 1996) models
with the estrous cycle with the highest levels occurringhave demonstrated that secretory IgA is capable of form-
during proestrus (Wira and Sandoe, 1977, 1980; Wira eting intracellular complexes with viruses and inhibiting
al., 1994). The migration of lymphocytes into the genitalvirus replication and subsequently preventing primary or
tract is also influenced by the estrous cycle since in-resolving chronic infections.
creased numbers of IgA plasma cells are observed inThe presence of secretory IgA at the mucosal surface
genital tissues during proestrus and estrus (Canning and
Billington, 1983; McDermott et al., 1980; Rachman et al.,
1983). These cyclic changes in SC and total antibody1 To whom reprint requests should be addressed. Fax: (905) 521-
2613; E-mail: rosenthl@fhs.csu.mcmaster.ca. levels are also observed in humans (Schumacher, 1980;
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Sullivan et al., 1984; Suzuki et al., 1984; Usala et al., al., 1994; Milligan and Bernstein, 1995; Parr et al., 1994).
Recently we showed that intranasal (i.n.) immunization1989), suggesting that the hormones that control the re-
productive cycle are intimately involved in these with a recombinant adenovirus capable of expressing gB
of HSV-1 (AdgB8) induced both gB-specific IgA and IgGchanges. Indeed, progesterone and estrogen have been
shown to be directly responsible for influencing the levels in vaginal washes of mice (Gallichan and Rosenthal,
1995). In this study we examined the influence of theof SC and antibodies, as well as the numbers of B cells
in the genital tract (Parr and Parr, 1994a; Sullivan et al., estrous cycle on the levels of HSV gB-specific IgA and
IgG antibodies in the female genital tract following i.n.1983; Wang et al., 1996; Wira and Sandoe, 1977, 1980;
Wira et al., 1994). immunization with AdgB8. In addition, mice immunized
intranasally with AdgB8 were challenged intravaginallyAs mentioned, the induction of specific antibodies in
genital secretions is considered necessary for protection with HSV-2 and the subsequent pathology, viral replica-
tion, and B cell responses in the genital tissues wereagainst infection with sexually transmitted pathogens
such as herpes simplex virus (HSV) or HIV (Brandtzaeg evaluated.
et al., 1994; Mestecky, 1987; Mestecky et al., 1994; Mo-
gens and Russell, 1994). In examining the induction of MATERIALS AND METHODS
humoral immunity in the female genital tract, immuniza-
Animals and cell culturestion by systemic routes (sc, im, and ip) has been shown
to induce specific antibodies in several species including Female C57Bl/6 (H-2b) mice used in immunization and
humans (Bouvet et al., 1994; Gallichan and Rosenthal, challenge studies and in the evaluation of vaginal wash
1995; Miller et al., 1992; Nakao et al., 1994; Ogra and antibody levels were 6 to 8 weeks of age during primary
Ogra, 1973; Parr and Parr, 1990; Thapar et al., 1990a,b). immunization and were obtained from Charles River Lab-
Although high titers of specific IgG antibodies were in- oratories (Constant, Quebec, Canada). Mouse colonies
duced in these studies, the levels of specific IgA were were maintained on a 12-hr light/dark cycle. Vero and
generally low or not reported. As a mucosal route of 293 cells were grown in a-MEM (GIBCO Laboratories,
immunization, intravaginal (ivag) or intrauterine inocula- Burlington, Canada), supplemented with 10% fetal calf
tion has been shown by some groups to induce both serum (FCS; GIBCO) and 1% penicillin–streptomycin and
specific IgG and IgA antibodies in the genital tract (Milli- L-glutamine (GIBCO). 293-N2S cells are a nonadherent
gan and Bernstein, 1995; Ogra and Ogra, 1973; Wira et cell line derived from 293 cells and were grown in spinner
al., 1994). However, in many other studies the titers were flasks with Joklik’s media supplemented as above.
low or consisted mainly of IgG antibodies (Gallichan and
Rosenthal, 1995; Lehner et al., 1992; McDermott et al., Virus strains and inoculations
1990; Miller et al., 1992; Parr and Parr, 1994; Parr et al.,
The construction of the replication-competent recom-1988; Thapar et al., 1990a,b), perhaps attributable to the
binant adenovirus type 5 vector, AdgB8, was reportedgeneralized lack of secondary lymphoid nodules in the
elsewhere (Hutchinson et al., 1993). Briefly, AdgB8 con-genital tract (Parr and Parr, 1994). In contrast, immuniza-
tains the gB gene from HSV-1 coupled to the SV40 pro-tion at other mucosal sites (ig or i.n.) has been successful
moter and inserted into the E3 region of human adenovi-in generating specific IgG and IgA antibodies in the geni-
rus type 5. Recombinant adenoviruses were grown intal tract (Gallichan and Rosenthal, 1995; Lubeck et al.,
293-N2S cells, purified twice on CsCl gradients, and ti-1994; Muster et al., 1995; Wu and Russell, 1993). Few of
tered on 293 cells. HSV-2 strain 333 was propagated andthe studies concerned with specific antibodies in the
titered on Vero cells.genital tract took into account the stage of the reproduc-
For AdgB8 immunization, mice were ether anesthe-tive cycle during sampling and evaluation of antibody
tized, inverted, and inoculated i.n. with 108 PFU of AdgB8titers.
by introducing virus in 10 ml of phosphate-buffered salineHerpes simplex virus type 2 is a sexually transmitted
(PBS, pH 7.4) directly into the nares by means of a micro-agent that attaches, penetrates, and undergoes infec-
pipet. For ivag HSV-2 challenge, mice were first injectedtious cycles of replication in the epithelium of the genital
subcutaneously with 2 mg of progesterone/mousetract. Most studies concerned with protection against
(Depo-Provera; Upjohn, Don Mills, Ontario), and 5 daysgenital HSV-2 infection have focused on systemic immu-
later mice were anesthetized using halothane, swabbednization (Bernstein et al., 1990; Burke et al., 1994; Byars
ivag with a cotton applicator, placed on their backs, andet al., 1994; Heineman et al., 1995; Nakao et al., 1994;
infected intravaginally for 1 hr with 10 ml of HSV-2 whileStraus et al., 1994), despite the evidence supporting mu-
being maintained under anesthetic.cosal immunization as the optimum route for the induc-
tion of both IgA and IgG antibodies in the genital tract. Collection of fluids and estrus staging
The exception to this involves ivag immunization with
attenuated strains of HSV-2 that protected mice against Vaginal fluid for estrus staging and antibody determi-
nations was collected by pipetting 30 ml of PBS into andivag HSV-2 challenge (McDermott et al., 1987; Mclean et
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out of the vagina several times. The staging of the estrous amined individually, as ratios of IgG divided by IgA, or
as grouped percentages of maximum. Grouped percent-cycle for each mouse was based on a smear from these
washings (Allen, 1922). Smears were stained with Diff- ages of maximum were determined by first converting
the titers of anti-gB IgG and IgA into a percentage ofQuik (Baxter Scientific Products, Miami, FL). By examin-
ing the cells present in the smears we were able to maximum by dividing the titer determined for each day
by the maximum that we observed over the course ofdetermine whether the animal was in estrus, metestrus,
diestrus, or proestrus. The vaginal washings were then the two cycles for individual mice. In this way we were
able to pool the percentages of maximums for each es-centrifuged to remove particulate matter and the super-
natants were stored at 0207 for subsequent antibody trus stage from among several mice.
determination.
Lymphocyte isolation
Viral replication and pathology in the reproductive
tract Single cell suspensions from lymph nodes were pre-
pared by smashing the lymph nodes on a grid etched
Following ivag HSV-2 inoculation, mice were sampled
on plastic plates with an 18-gauge needle. To obtain
daily for 6 days by pipetting 30 ml of PBS into and out of
lymphocytes from the genital tract, the vagina, cervix, and
the vagina followed by a swabbing with a cotton applica-
uterine horns were removed from groups of five mice,
tor. Both the wash and the applicator were combined
minced with scissors, and digested with an enzyme solu-
with 0.97 ml of PBS and frozen at 0707. Viral titers were
tion containing collagenase (0.5 U/ml, Boehringer Mann-
determined by plaque assay on Vero cell monolayers.
heim), Dispase II (1.2 U/ml, Boehringer Mannheim), and
The dilution of each vaginal wash supernatant was con-
DNAse (5 U/ml, Calbiochem). Two successive digests
sidered to be 1002.
were performed for 1 hr at 377C. Lymphocytes were en-
Genital pathology was monitored daily following HSV-2
riched by passing the cell fractions over Ficoll gradients
challenge and scoring was performed blinded. Pathology
and then culturing for 2 hr to remove adherent epithelial
was scored on a 5-point scale: 0, no apparent infection;
and fibroblast cells.
1, slight redness of external vagina; 2, redness and swell-
ing of external vagina; 3, severe redness and swelling of
Antibody-secreting cell (ASC) enumeration byexternal vaginal and surrounding tissue; 4, genital ulcer-
ELISPOT assayation with severe redness, swelling and hair loss of geni-
tal and surrounding tissue; 5, severe genital ulceration
Ninety-six-well filtration plates backed with nitrocellu-
extending to surrounding tissue. Mice were sacrificed
lose membrane (Millipore Corp., Bedford, MA) were
upon reaching stage 5.
coated with 10 mg/ml recombinant HSV-2 gB (provided
by R. L. Burke) or 1/500 dilution of goat anti-mouse IgGAntibody determination
or IgA (Southern Biotechnology Associates) in PBS, and
kept overnight at 47. A PBS solution containing 10 mg/Total and HSV gB-specific antibody titers were deter-
mined by ELISAs performed in flat-bottomed microtiter ml bovine serum albumin, pH 7.4, was used to block any
nitrocellulose not precoated with antibody or gB protein.plates (Costar, Cambridge, MA). Plates were precoated
with 2.5 mg/ml recombinant HSV-2 gB (kindly provided Serially diluted single cell suspensions of iliac lymph
nodes or genital tract digests plus supplemented RPMIby R. L. Burke, Chiron, Emeryville, CA) for gB-specific
antibody titers, and 1/1000 dilution of goat anti-mouse media (10% FCS) were plated at 377 for 16 hr. The number
of plasma cells in each preparation secreting total orIgG or IgA (Southern Biotechnology Associates, Bir-
mingham, AL) for total antibody titers, in borate-buffered HSV gB-specific IgA or IgG antibody was determined by
washing each well with PBS–Tween 20 to remove cellssaline, pH 8.5, and kept overnight at 47. A Tris-buffered
saline solution containing 10 mg/ml bovine serum albu- and developing the plate by the addition of biotinylated
goat anti-mouse IgA or anti-IgG (Southern Biotechnologymin, pH 7.4, was used to block any plastic not precoated
with antibody or gB protein. Serially diluted samples of Associates), followed by avidin–peroxidase. Spots repre-
senting individual antibody-secreting cells were visual-hyperimmune control, test sera, or sample supernatants
were added, followed by either biotin-labeled goat anti- ized by developing with peroxidase substrate containing
H2O2 and 3-amino-9-ethylcarboazole in acetate buffer.mouse IgG or IgA antibody (Southern Biotechnology As-
sociates, Birmingham, AL). The labeling reagent was al- Spots were enumerated by digitized image analysis and
discrimination from background was based on gray den-kaline phosphate (ExtrAvidin; Sigma, St. Louis) and the
ELISA amplification system (GIBCO, Burlington, Ontario) sity and then size (program written by Dr. L. Arsenault,
Microscopy Group, McMaster University, Hamilton, On-was used as a substrate. Antibody titers represent the
inverse dilution of the sample at which two times the tario). Counts were visually confirmed in case of overlap-
ping spots. Results are expressed as the mean numberbackground absorbance of control or lavage fluid from
uninfected mice was reached. Antibody levels were ex- of ASC per million mononuclear cells for each tissue.
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Statistical analysis
Data were analyzed using the GraphPAD InStat pro-
gram (GraphPAD Software, San Diego, CA). For compari-
sons between two groups, data were analyzed by Stu-
dent’s t test or Fisher’s exact test as appropriate. Compar-
ison among the means of multiple groups was carried
out using analysis of variance.
RESULTS
Variation in specific vaginal wash antibody levels
during the estrous cycle
In our previous studies we observed the presence of
specific antibodies to gB of HSV-1 in the vaginal washes
of mice immunized i.n. with AdgB8 (Gallichan and Rosen-
thal, 1995). The levels of these antibodies tended to vary
greatly between mice and within individual mice over
time. Since immunoglobulin levels are influenced by the
estrous cycle, we determined the titers of HSV gB-spe-
cific IgG and IgA in vaginal washes on a daily basis and
correlated them with the stage of the estrous cycle. Fig-
ure 1A shows data from a representative mouse immu-
nized 6 weeks previously with AdgB8 and sampled daily
over two estrous cycles. The absolute titers of gB-specific
antibodies in this mouse demonstrated that, indeed,
there was a large variation from day to day. Moreover,
there appeared to be a cyclic fluctuation in the titers of
gB-specific IgG and IgA that varied with the stage of the
FIG. 1. The effect of the estrous cycle on gB-specific antibody levelsestrous cycle. Anti-gB IgA titers were generally highest
in the vaginal washes of a mouse immunized intranasally with AdgB8.during estrus and, conversely, anti-gB IgG titers tended
The stage of the estrous cycle was determined daily by cytology fromto be lowest during estrus and higher during other peri-
a smear of the vaginal washes of a representative mouse over a 16-
ods of the cycle. To examine these fluctuations in a group day period: estrus (E), metestrus (M), diestrus (D), proestrus (P). (A)
of mice, titers from the vaginal washes of four mice immu- The titers of HSV gB-specific IgA (hatched bars) and IgG (solid bars)
were determined daily using a gB-specific ELISA. (B) The ratios of HSVnized i.n. with AdgB8 were pooled over two estrous cy-
gB-specific IgG to IgA over the 16 days for the same mouse in A.cles and expressed as percentages of maximums to ac-
commodate the varying magnitudes of specific antibod-
ies observed. In Fig. 2A it is clear that the levels of anti-
gB IgA and IgG fluctuated with the estrous cycle. In fact, Figure 1B demonstrates that the gB-specific IgG-to-IgA
the levels of anti-gB IgA during estrus were significantly ratios from the vaginal washes of the mouse in Fig. 1A
higher than those observed during diestrus or proestrus followed a cyclic pattern and were highest during dies-
(P £ 0.05). In contrast, the levels of anti-gB IgG observed trus and lowest during estrus. In addition, there was as
during diestrus were significantly higher than during es- much as a 93-fold difference in ratios between estrus
trus (P £ 0.001) (Fig. 2A). This inverse relationship be- and diestrus. These cyclic trends were similar in all mice
tween isotype expression indicates that over the course that we examined. To examine a group of mice, the ratios
of the estrous cycle specific IgA levels are highest during of anti-gB IgG to IgA from four mice were pooled (over
periods of estrus and lowest during diestrus, whereas two cycles each) from each of the four estrous stages
specific IgG levels are highest during periods of diestrus by first normalizing the ratios in each mouse to a scale
and lowest during estrus. The levels of specific IgA and of 1.0. The ratios in Fig. 2B demonstrate that the relative
IgG during metestrus and proestrus lie in between. levels of gB-specific IgG compared to IgA were signifi-
cantly higher during diestrus compared to all other
Ratios of specific IgG-to-IgA antibodies in vaginal
stages (P £ 0.001). In addition, the ratio at diestrus was
washes
15 times greater than during estrus, and conversely, dur-
ing estrus the levels of specific IgA were relatively muchThe relationship between the levels of specific IgG
relative to IgA was examined at each stage of the estrous higher than IgG. The inverse relationship between levels
of gB-specific IgG and IgA at each stage of estrous wascycle by determining the ratios of gB-specific IgG to IgA.
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observed in the vaginal washes of mice infected during
diestrus or late metestrus. There was no virus replication
observed in mice infected at estrus. The results pre-
sented in Table 1 are representative of several experi-
ments examining a number of animals at each stage.
Interestingly, the dose of HSV-2 used for infection repre-
sents more than a 1000-fold lethal dose (unpublished
data). Thus mice appeared to be highly resistant to intra-
vaginal HSV-2 infection at estrus. The stages of the es-
trous cycle occurring on days subsequent to infection
did not seem to influence the amount of virus recovered
in vaginal washes (data not shown). By Day 6 the mice
that were infected during diestrus or late metestrus had
developed moderate to severe pathology of the exterior
genital tissues. In contrast, mice infected during estrus
displayed no genital pathology.
To examine the site and extent of tissues infected, the
uterus, vagina (including the cervix), and nerves innervat-
ing the genital tissues were isolated. Only the tissues
from mice infected during diestrus or late metestrus con-
tained virus (Table 1). The level of infection in vaginal
tissues was severalfold higher than in the uterus of all
mice we examined, indicating that the primary site of
HSV-2 infection following intravaginal inoculation is in
the vagina. Virus was also observed in the nerves of
severely infected animals. These results indicate that
mice are primarily susceptible to HSV-2 infection during
early to late periods of diestrus and that the primary site
of infection is in the vagina, with further infection of the
FIG. 2. The relative changes in total HSV gB-specific IgG and IgA
uterus and ultimately the nerves occurring in severelyantibody levels during the estrous cycle in a group of mice immunized
infected animals.intranasally with AdgB8. The stages of the estrous cycle were deter-
mined daily by cytology from a smear of the vaginal washes of a group
of four mice each examined daily over two estrous cycles. Estrus (E), Influence of progesterone on specific antibody ratios
n  16; metestrus (M), n  9; diestrus (D), n  8; proestrus (P), n  in vaginal washes
5. (A) The titers of gB-specific IgA (hatched bars) and IgG (solid bars)
in each mouse were expressed as a percentage of maximum observed Administration of progesterone induces mice into a
over the two cycles and then grouped between and within mice ac- diestrus-like state and is known to make mice highly
cording to the stage of the estrous cycle. HSV gB-specific IgG during susceptible to intravaginal infection with HSV (Parr et al.,diestrus was significantly greater than during estrus, P £ 0.001; HSV
1994). To determine the influence of this treatment ongB-specific IgA during estrus was significantly greater than during dies-
specific antibody levels in the genital tract we examinedtrus or proestrus, P £ 0.05. (B) The ratios of HSV gB-specific IgG to
IgA for each day over two estrous cycles for each of the four mice in the ratios of vaginal wash anti-gB IgG to IgA in six mice
A were normalized to a scale of 1 and then grouped together. Anti-gB that were immunized intranasally with AdgB8. By Day 3
IgG to IgA during diestrus was significantly greater than during the the ratios had increased dramatically and were signifi-other three stages, P £ 0.001.
cantly greater than the preceding days (P  0.05) (Fig.
3). In addition, by Day 3 post-hormone treatment all six
mice had entered a diestrus-like state which was main-also observed for total antibodies in vaginal washes
tained for more than a week. During this diestrus-like(data not shown).
state the titers of gB-specific IgA antibodies were ex-
Influence of the estrous cycle on susceptibility to tremely low or undetectable.
HSV-2 infection
Intranasal immunization protects against intravaginal
To examine the influence of the estrous cycle on sus- HSV-2 infection
ceptibility to ivag HSV-2 infection, unimmunized mice
were infected at various estrous stages and monitored Next we determined whether mice immunized intrana-
sally with AdgB8 were protected from ivag HSV-2 infec-for virus replication by examining vaginal fluids daily and
tissues on Day 6 after infection. Table 1 demonstrates tion during a progesterone-induced diestrus-like state.
Five days following progesterone treatment, control (un-that over the 6 days examined, virus replication was only
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TABLE 1
Effects of the Estrous Cycle on HSV-2 Replication in the Genital Tract Following Intravaginal Infection
Estrous stage and vaginal wash HSV-2 titer (102 PFU/ml)a
Day 1 Day 3 Day 5 HSV-2 titer (102 PFU/tissue)b
Estrous
stagec Stage Titer Stage Titer Stage Titer Vagina Uterus Nerves
E M 0 M 0 P 0 0.05 0.05 0.05
M D 1 D 2 D 110 310 0.3 0.05
D D 11 D 740 P 410 2300 32 5.0
P E 1 E 0 M 0 0.05 0.05 0.05
a Mice were inoculated intravaginally with 2 1 107 PFU HSV-2 and vaginal washes were taken daily for determination of virus titers and the
estrus stage.
b On the 6th day following infection tissues were isolated and homogenized, and viral titers were determined.
c Estrous staging was determined histologically: estrus (E), metestrus (M), diestrus (D), proestrus (P).
immunized) and immunized mice were inoculated ivag was also significantly reduced in the i.n.-immunized mice
over the 6 days (P 0.0001). Of the 14 AdgB8-immunizedwith a lethal dose of HSV-2 (Table 2). Subsequent daily
evaluation of genital pathology, survival, and virus repli- mice, 5 were completely protected from any discernable
genital pathology. Interestingly, these 5 mice werecation in vaginal washes of control and immunized ani-
mals was determined in a blinded fashion. All of the among the mice that had cleared any signs of viral repli-
cation by Day 5. The remaining 9 mice all developedcontrol animals were infected with virus and demon-
strated genital pathology by Day 4, eventually suc- genital pathology; however, 4 of these mice displayed
only minor symptoms (pathology score £ 3), and subse-cumbing to infection on Day 6 (having reached a genital
pathology score of 5). In contrast, mice immunized i.n. quently cleared the infection by Day 7 and any signs of
pathology by Day 12. Therefore, a significant number ofwith AdgB8 demonstrated a significant level of protection
against HSV-2 infection. Although virus replication was immunized mice (9 of the 14) survived past acute infec-
tion (P  0.005).observed in the genital tracts of all the immunized mice
for the first 4 days postinfection, by Day 5, virus was
Detection of specific antibody-secreting cells in theisolated from only 8 of the immunized mice (P £ 0.01).
genital tractIn addition, by Day 5 there was a significant decrease
in viral replication in the 6 remaining immunized mice (P The presence of ASC specific for gB of HSV-2 was 0.0001). The severity of infection or genital pathology examined in the genital tracts and iliac lymph nodes (ILN)
of immunized and control mice following an ivag HSV-2
challenge. High numbers of gB-specific IgA and IgG ASC
were present in both the genital tracts and the draining
ILN of i.n.-immunized mice 6 days following ivag HSV-2
challenge (Table 3). The gB-specific ASC observed in the
ILN represented 65 and 35% of the total IgA and IgG ASC
present, respectively. In the genital tracts they repre-
sented 8 and 92% of the total IgA and IgG ASC present,
respectively. This is in contrast to control animals in
which no gB-specific ASC were observed in the genital
tissues and only a small number of IgG ASC were ob-
served in the ILN. The IgG ASC present in the ILN of
control animals likely represents the development of a
primary response and consisted of only 2% of the total
IgG ASC present (and was 19 times less than that ob-
FIG. 3. The effect of progesterone treatment on the ratios of HSVgB- served in the ILN of immunized mice). These results were
specific IgG to IgA in the vaginal washes of mice immunized intrana- confirmed in two separate experiments.
sally with AdgB8. The vaginal washes of a group of six mice immunized
3 weeks previously were sampled daily following sc injection of proges-
DISCUSSIONterone, and the stage of the estrous cycle was determined by cytology.
The ratio of HSVgB-specific IgG to IgA was determined for each vaginal
The capability of the female genital tract to maintainwash and then normalized to a scale of 1 for each mouse prior to
grouping. Day 3 was significantly greater than Day 0, P £ 0.05 (*). a high level of sterility and at the same time provide an
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TABLE 2
Protection and Virus Replication in the Genital Tracts of Mice Immunized Intranasally with AdgB8 and Challenged Intravaginally with HSV-2
Virus isolationb Vaginal viral replicationc
Groupa Days 1 – 4 Day 5 Day 3 Day 5 Severityd Protectione Survivalf
Unimmunized 14/14 14/14 3.6 (0.50) 3.6 (0.35) 8.9 (2.2) 0/14 0/14
Immunized 14/14 8/14*** 3.5 (0.57) 2.4 (0.35)* 3.4 (3.1)* 5/14**** 9/14**
Note. Significance between AdgB8-immunized and unimmunized mice: *P  0.0001; **P  0.005; ***P  0.01.; ****P  0.025.
a Mice were intravaginally challenged with 2 1 104 PFU of HSV-2; immunized mice were innoculated with AdgB8 3 weeks previously.
b Number of mice in which virus was detected/total.
c Mean { SD log10 PFU; calculated using only animals that experienced viral replication.
d Mean { SD; measured as area under the lesion score–day curve for first 6 days.
e Number of mice with that demonstrated no overt genital pathology/total (i.e., score of 0).
f Number of mice surviving infection/total.
environment suitable for conception requires the coordi- murine genital tract and, anatomically, IgA originates
mainly from the uterus/endocervix and IgG from the va-nation of a large number of specific and nonspecific fac-
tors. The main specific factors that contribute to protec- gina (Mestecky, 1987; Parr and Parr, 1990, 1994; Wira et
al., 1994). In our previous investigations, we demon-tion in the genital tract include the effector functions of
humoral- and cell-mediated immunity (Brandtzaeg et al., strated that i.n. immunization with a recombinant adeno-
virus vector capable of expressing gB of HSV-1 (AdgB8)1994; Mestecky et al., 1994; Parr and Parr, 1994; Tristram
and Ogra, 1994; Underdown and Mestecky, 1994). In- induced both IgA and IgG specific for gB in the genital
tract (Gallichan and Rosenthal, 1995). The current studydeed, both arms of the immune system have been shown
to be important for resistance to various pathogens that demonstrates that the levels of specific IgG and IgA anti-
bodies in the genital tract of intranasally immunized miceinfect the female genital tract (Brunham et al., 1983; Eis-
Hubinger et al., 1993; McDermott et al., 1987, 1989, 1990; vary inversely with each other and are dependent on the
stage of the estrous cycle. Indeed, specific IgA titersMerriman et al., 1984; Parr and Parr, 1994; Whaley et al.,
1994). Arguably, humoral immunity or antibodies are the were higher during estrus than diestrus and specific IgG
titers were higher during diestrus than estrus. This wasfirst specific barrier encountered by sexually transmitted
pathogens (Brandtzaeg et al., 1994; Mestecky, 1987; further demonstrated in hormone-treated mice where
progesterone administration induced a diestrus-likeMestecky et al., 1994; Underdown and Mestecky, 1994).
Both IgA and IgG are present in secretions from the state that resulted in elevated specific IgG-to-IgA ratios.
In fact, while specific IgG titers reached their highest
levels, specific IgA titers were extremely low to undetect-TABLE 3
able. The fluctuations in levels of specific antibodies that
HSVgB-Specific Antibody-Secreting Cells in Genital Tissues of In- we detected are similar to those reported for total (Parr,
tranasally Immunized Mice 6 Days Following Intravaginal HSV-2 Chal-
1994; Sullivan et al., 1984; Wang et al., 1996; Wira et al.,lenge
1994) and specific (Wira and Sandoe, 1980) antibodies
during the various stages of the estrous cycle or underMean HSVgB-specific ASC/million mononuclear
cells (SD)b the influence of sex hormones.
This inverse relationship in specific antibody levels
% of % of likely reflects the changes that occur in the female repro-
Immunizationa IgA total IgG total
ductive tract during the course of the estrous cycle. Dur-
ing estrus, or the time of mating, the female genital tractILN
i.n. AdgB 66.8 { 6.3 65 1810 { 151 34.5 is subjected to numerous pathogens (Parr and Parr, 1994;
Unimmunized 1 1 95.0 { 56.5 1.6 Profet, 1993; Tristram and Ogra, 1994). In fact, sperm has
Genital tract been shown to be a vector for bacteria, whereby the
i.n AdgB 68 { 4.0 8.1 1275 { 170 91.6
bacteria attach to the tails of sperm as they move up theUnimmunized 1 1 1 1
reproductive tract (Profet, 1993). In terms of protection at
a Mice were unimmunized or immunized intranasally with AdgB8 3 mucosal surfaces secretory IgA is an important compo-
weeks prior to ivag HSV-2 challenge. Six days following challenge the nent (Brandtzaeg et al., 1994; Magnusson and Stjern-
ILN and genital tracts were isolated from groups of five mice and the strom, 1982; Mestecky, 1987; Mestecky et al., 1994; Mo-
mononuclear cells were isolated and analyzed by ELISPOT for HSVgB-
gens and Russell, 1994; Underdown and Mestecky, 1994)specific antibody-secreting cells.
and therefore, it follows that there be high levels of IgAb Results are expressed as the means{ SD of triplicate wells and as
a percentage of total antibody-secreting mononuclear cells observed. present during this period to deal with the increased
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pathogen load associated with mating. Indeed, antibod- to influence virus replication. The difference in thickness
and permeability of the vaginal epithelium, as well asies can be found in the uterine lumen bound to bacteria
shortly after mating (Parr and Parr, 1985). There may availability of viral receptors, during these periods may
be responsible (Allen, 1922; Parr and Parr, 1994).be two hormonally controlled factors that contribute to
increased IgA levels during estrus. First, there is an in- To examine immunity in the genital tract within the
environment of increased viral susceptibility (but de-creased migration of plasma cells to the genital tract
resulting in a greater number of IgA plasma cells during creased IgA levels) animals were induced into a diestrus-
like state by progesterone treatment prior to intravaginalproestrus and estrus (McDermott et al., 1980; Rachman
et al., 1983). Second, there is an increase in production HSV-2 challenge. Our results demonstrate that while
none of the control animals survived infection, a signifi-of SC in the uterine epithelium that fluctuates with the
estrous cycle and is associated with estradiol adminis- cant number of mice immunized intranasally with AdgB8
did survive (Table 2). Subsequent studies showed thattration (Sullivan et al., 1983; Wira et al., 1994). Interest-
ingly, exogenous estradiol and progesterone influence intranasally immunized mice infected with a lower but
still lethal dose of virus were completely protected fromthe levels of total IgA or IgG in the genital tract as well
as both of the above phenomena, suggesting that the mortality as well as genital pathology (W. S. Gallichan
and K. L. Rosenthal, manuscript in preparation). Of inter-increased IgA levels observed during estrus are directly
a result of the fluctuating hormone levels that occur over est was the fact that although gB-specific antibodies
(mainly IgG) were present at the time of infection in im-the course of the estrous cycle (Wang et al., 1996; Wira
et al., 1994; Wira and Sandoe, 1980). munized animals, sterile immunity was not observed and
the viral replication that occurred over the first 4 daysThe factors contributing to the relative decrease in
IgG during estrus are likely due in part to architecture postinfection was similar to that occurring in control
mice. In addition, while some immunized mice developedchanges in the epithelium of the vagina. IgG originates
mainly from serum transudation through the vagina and genital pathology, several of these completely cleared
the primary infection and lacked any genital morbidity bythe vaginal epithelium is known to undergo changes from
a thin (3 to 7 layers) stratified epithelium at diestrus to a Day 12. These results suggest that the induction of spe-
cific anamnestic responses and not neutralization by mu-thick (12 to 13 layers) keratinized epithelium with a clearly
defined basement membrane at estrus (Allen, 1922; Parr cosal IgG antibodies present during initial infection were
responsible for subsequent protection. In examining theand Parr, 1994). These changes are also influenced by
hormones with estrogen-dominated and progesterone- immune mechanisms present during the period of viral
clearance, we observed that the draining ILN and thedominated vaginal epithelium being similar to that of es-
trus and diestrus, respectively (Parr et al., 1994). The genital tissues of immunized but not control mice con-
tained a large percentage of ASC specific for gB of HSV-physical structure of the vaginal epithelium, which is thin-
ner during diestrus, also explains the increase in specific 2. Both IgG- and IgA-secreting plasma cells were present
demonstrating that intranasal immunization inducedIgG that we observed during this stage and which is
likely due to increased serum transudation. In fact, pro- memory lymphocytes of both isotypes that were capable
of responding to infection and entering the genital tract.teins can penetrate the vaginal epithelium during dies-
trus and IgG has been localized in the intercellular Interestingly, the gB-specific ASC in both the ILN and
the genital tissues represented a large percentage of thespaces during this period (Parr and Parr, 1994). It would
thus appear that the results presented here reflect the total ASC present; however, the gB-specific IgA ASC in
the genital tissues were not as highly represented (Tableability of the genital tract to compensate for the decrease
in protective IgG during estrus by actively recruiting IgA 3). This may be due to the progesterone-dominated envi-
ronment since it has been observed that the circulationplasma cells and transporting IgA via SC into the uterine
lumen. of IgA plasma cells into the genital tissues decreases
during diestrus (McDermott et al., 1980). Nevertheless,The physical changes that occur in the vagina during
the transition from diestrus to estrus are likely in prepara- gB-specific IgA ASC were present in the genital tissues
during the resolution phase of infection and were moretion for mating and the increased pathogen load associ-
ated with this activity. Our data clearly show that unimmu- numerous than the HSV-2-specific ASC reported in simi-
lar experiments where mice were protected from a lethalnized mice were susceptible to intravaginal HSV-2 infec-
tion during diestrus but not during estrus. Indeed, even HSV-2 challenge following intravaginal immunization
with an attenuated HSV-2 virus (Milligan and Bernstein,at 1000-fold lethal dose mice were resistant to ivag infec-
tion during estrus. Thus our findings confirm those origi- 1995). Interestingly, Eis-Hubinger et al. (1993) demon-
strated that administration of gB-specific monoclonal an-nally made by Tepee et al. (1990) and Parr et al. (1994).
Following infection at diestrus, the stage of the estrous tibodies resulted in the rapid clearance of virus from
the genital tracts of mice that had an established HSV-cycle did not affect the level of virus recovered in vaginal
washes. In other words, once infection was established 1 infection. Moreover, recent studies have revealed that
in addition to neutralization at the mucosal surface, se-subsequent stages of the estrous cycle did not appear
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